Propranolol Dosing for Infantile Hemangioma
Standard Dosing Protocol
- The American Academy of Pediatrics recommends starting propranolol at 1 mg/kg/day divided into 2-3 doses, then increasing after 24 hours to a maintenance dose of 2 mg/kg/day for uncomplicated cases, with a maximum of 3 mg/kg/day for non-responders 1, 2
- The British Society for Paediatric Dermatology suggests escalating to a maintenance dose of 2 mg/kg/day divided into 2-3 doses after 24 hours 1, 2
- The maintenance dose range is 2-3 mg/kg/day based on high-quality RCT data showing 60% complete/nearly complete resolution at 3 mg/kg/day for 6 months versus 4% with placebo 2
- The maximum dose is 3 mg/kg/day for non-responders 1, 3
Administration Guidelines
- The American Academy of Pediatrics recommends giving propranolol with or after feeding to reduce hypoglycemia risk 2, 4
- The British Society for Paediatric Dermatology suggests holding doses during reduced oral intake or vomiting to prevent hypoglycemia 2, 4
Modified Dosing for High-Risk Patients
- The American Academy of Pediatrics recommends a starting dose of 0.5 mg/kg/day for preterm infants, low birthweight, faltering growth, or conditions predisposing to hypoglycemia 1, 5
- The British Society for Paediatric Dermatology suggests obtaining brain MRI/MRA, echocardiogram, and ECG before full-dose propranolol for patients with PHACE syndrome 1, 3
Treatment Duration
- The American Academy of Pediatrics recommends continuing treatment until at least 12 months of age to minimize rebound growth risk 2, 4
- The British Society for Paediatric Dermatology suggests that 6 months duration is superior to 3 months (60% vs lower response rates) 2
Pre-Treatment Assessment
- The American Academy of Pediatrics recommends a thorough history and physical examination including auscultation, peripheral pulses, abdominal exam for hepatomegaly 5
- The British Society for Paediatric Dermatology suggests measuring heart rate and blood pressure before starting propranolol 5
Monitoring During Treatment
- The American Academy of Pediatrics recommends routine follow-up every 2-3 months for stable patients 1, 3
- The British Society for Paediatric Dermatology suggests adjusting the dose for weight at clinic visits 1, 3
Critical Safety Considerations
- The American Academy of Pediatrics recommends holding propranolol during reduced oral intake or vomiting (hypoglycemia risk) 2, 5, 4
- The British Society for Paediatric Dermatology suggests that contraindications include heart block, decompensated heart failure, asthma/obstructive airway disease, cardiogenic shock, and sinus node dysfunction without pacemaker 4, 3, 5